Background Non-alcoholic fatty liver disease, or as recently proposed 'metabolic-associated
fatty liver disease'(MAFLD), is characterized by pathological accumulation of triglycerides …

Nonalcoholic fatty liver disease (NAFLD) is a component of the metabolic syndrome, with a
clinical spectrum ranging from simple fatty liver to steatohepatitis, cirrhosis, and …

The metabolic-associated fatty liver disease (MAFLD) is a condition of fat accumulation in
the liver in combination with metabolic dysfunction in the form of overweight or obesity and …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in
Western countries and is considered the hepatic manifestation of metabolic syndrome. The …

Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic lipid accumulation in
the absence of excess alcohol intake. NAFLD is the most common chronic liver disease, and …

After recently being recognized as a feature of the metabolic syndrome, fatty liver has
evolved as a key player in the pathogenesis of dyslipidemia. Development of nonalcoholic …

Triglyceride molecules represent the major form of storage and transport of fatty acids within
cells and in the plasma. The liver is the central organ for fatty acid metabolism. Fatty acids …

Nonalcoholic fatty liver disease (NAFLD), an escalating health problem worldwide, covers a
spectrum of pathologies characterized by fatty accumulation in hepatocytes in early stages …

Abstract Purpose of Review Metabolic-associated fatty liver disease (MAFLD) is a condition
of fat accumulation in the liver that occurs in the majority of patients in combination with …

Background Non-alcoholic fatty liver disease (NAFLD), characterized as excess lipid
accumulation in the liver which is not due to alcohol use, has emerged as one of the major …